Investor Presentaiton

Annual price increase reporting: Data elements • The length of time the prescription drug has been on the market • The factors that contributed to the price increase, including a narrative description and explanation of all major financial and nonfinancial factors that influenced the decision to increase the wholesale acquisition cost of the drug product and to decide on the amount of the increase The name of any generic version or biosimilar of the prescription drug available for sale in the United States at the time of the report 17

View entire presentation